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Edited by Masayuki MiyasakaAbstract Interactions between Trypanosoma cruzi and the
extracellular matrix play an important role in cellular invasion.
Here we show that T. cruzi increases the levels of thrombospon-
din-1 (TSP-1) expression in host cells during early infection. Sta-
ble RNA interference of host cell TSP-1 knocks down the levels
of TSP-1 transcripts and protein expression in mammalian cells
causing inhibition of T. cruzi infection. Addition of TSP-1 to
these cells restores infection. Thus, host TSP-1, regulated by
the parasite, plays a crucial role in early infection. This is the
ﬁrst report showing that a human parasite modulates TSP-1
expression to facilitate infection.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Trypanosoma cruzi1. Introduction
Trypanosoma cruzi, the causative agent of Chagas’ disease,
needs to invade host cells to establish and cause infection.
The parasite must navigate the extracellular matrix (ECM) in
order to infect mammalian cells. Amongst the glycoproteins
of the ECM, the thrombospondins constitute a unique multi-
domain protein that are synthesized, secreted and incorporated
into the ECM by many cell types [1,2]. Thrombospondins are
unique members of the ECM in that they have been described
as ‘matricellular’ proteins because they modulate cell function
but they do not play a direct role in the structure of the ECM.
The ﬁve diﬀerent forms of thrombospondins (TSP1-5) are di-
vided into two subgroups according to their oligomerization
properties and molecular architecture. Subgroup A (TSP-1
and -2) are members of the thrombospondin type1(TSP1) re-
peat supergene family which forms homotrimers and subgroup
B (TSP-3, -4 and -5) forms homopentamers [3,4]. TSP-1 con-
tains several distinct domains, including an N-terminal heparinAbbreviations: RNAi, RNA interference; shRNA, short hairpin RNA;
TSP-1, thrombospondin-1; ECM, extracellular matrix; HCASM,
human coronary artery smooth muscle
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doi:10.1016/j.febslet.2006.03.054binding domain (HBD), a procollagen region, three type I
(properdin) repeats, three type 2 (epidermal growth factor-like)
repeats, type 3 repeats (calcium binding), and a C-terminal do-
main. All the other thrombospondins except TSP-5 have an
HBD domain [5]. TSP-1 binds to speciﬁc cell-surface receptors,
cytokines, proteases, and growth factors during which they
help deﬁne cellular function in that environment [6,7]. TSP-1
also interacts with structural proteins such as collagens, ﬁbro-
nectin, and laminins [3,7]. The co-expression of one or more
thrombosopondins can be found in most adult tissues, and
subgroup A thrombospondins are more highly expressed dur-
ing cellular injury, stress and tissue remodeling. Most throm-
bospondin types are expressed in smooth muscle cells,
ﬁbroblasts, and endothelial cells, among others. Most tissues
express at least one type of thrombospondin [1].
Previous studies have shown that T. cruzi molecules bind to
immobilized laminin [8], and that human galectin-3 enhances
this interaction [9], suggesting that the trypanosome interacts
with the ECM. In addition, it was suggested that T. cruzimight
have receptors for thrombospondin [10]. However, the role
that host TSP isoforms may have in the process of microbial
infections is unknown. Since nearly all cells that T. cruzi infects
are surrounded by basement membranes, of which several TSP
isoforms are important constituents, the ability of the parasite
to eﬀectively regulate and interact with TSP-1 is critically
important for its passage through the membrane barrier. In
this study, we test the hypothesis that T. cruzi binds to human
cells to regulate the expression of TSP-1, which is required for
T. cruzi infection.
In this paper we report the novel observation that early T.
cruzi infection of human coronary artery smooth cells upregu-
lates the expression of TSP-1 and that knocking down the
expression of TSP-1 by RNA interference (RNAi) dramati-
cally reduces T. cruzi infection of human cells.2. Materials and Methods
2.1. Microorganism
The highly infective trypomastigote clone, MMC 20A derived from
the Tulahuen strain of T. cruzi [11] was used. Pure culture trypomastig-
otes were obtained from the supernatant of heart myoblast monolayers
as described [11].
2.2. Cellular infection assays
Parasite binding to human cells was evaluated at 2 h by ﬂuorescence
microscopy using FITC labeled antibodies to a trypomastigote surface
protein and DAPI [12]. Bound FITC-ﬂuorescent parasites per 200 cells
were microscopically determined. Parasite entry was evaluated at theblished by Elsevier B.V. All rights reserved.
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tained by subtracting the number of bound FITC-ﬂuorescent parasites
from the total number of DAPI-stained kinetoplast DNA parasites per
200 host cells. Parasite multiplication within cells was evaluated at 72 h
using standardized procedures [11]. In some cellular infection assays,
HeLa or Vero cells were serum starved in the presence of DMEM or
MEM for 24 h and then treated with or without TGF-b1 (R&D Sys-
tems, USA) at the concentration of 5 ng/ml for 24 h followed by expo-
sure to parasites. In other assays, TSP-1 (Protein Sciences, USA) at the
concentration of 8 lg/ml was added to HeLa cells transfected with con-
struct T1 for 30 min and then used for infection assays. Infection as-
says using primary human coronary artery smooth muscle
(HCASM) cells, HeLa and Vero cells were done in triplicate and exper-
iments were repeated three times.
2.3. RNA extraction and quantitation of host gene expression by real-
time PCR
Total RNA was extracted using TriZol (Invitrogen, USA) and geno-
mic DNA was removed with RQ1 (Promega, USA). First strand
cDNA was synthesized using SuperScript II (Invitrogen). The cDNAs
were used for real-time PCR experiments on an iCycler (Biorad, USA).
The reaction mixture (25 ll) was set up as described by the manufac-
turer (Biorad) in triplicate. The cycling conditions for TSP-1 were as
follows: 95 C for 3 min, 40 cycles of 94 C for 30 s and 56 C for
45 s. We used an annealing temperature of 60 C for the cycling proto-
col for TSP-2, TSP-3, and TSP-4, and human 18s RNA. Melt curve
analyses were performed from 95 to 55 C during which 100 continu-
ous ﬂuorescence readings were obtained. The quantity of human 18s
RNA was used to normalize each corresponding transcript. The prim-
ers used are shown in Table 1.Table 2
Oligonucleotides used for generating shRNA-targeting TSP-1 in the cells
Name Sequence (sense 50 ﬁ 30 and antisense 3 0 ﬁ
T1 sense TCGAGGGGACCATGCTCCAGCCACCATCCTG
T1 antisense CCCCTGGTACGAGGTCGGTGGTAGGACAACT
T1 sense scrambled TCGAGGGGACCATGCTGTACATCCCCGTCAC
T1 antisense scrambled CCCCTGGTACGACATGTAGGGGCAGTGAGCT
T2 sense TCGAG TTACATCACCAACGCAGTCCTTGCC
T2 antisense CAATGTAGTGGTTGCGTCAGGAACGGAGGCT
T3 sense TCGAGGGAGAGTTGCAGAGCCGGATCCTTGT
T3 antisense CCCTCTCAACGTCTCGGCCTAGGAACACTCT
The sense oligonucleotides were annealed with the antisense oligonucleotides
vector. TSP-1 containing sequences represented in bold andHindIII site that s
sequences are represented in regular text.
Table 1
Real-time PCR primers
Target primer sequence (50 ﬁ 30) GeneB
Thrombospondin-1 NM_00
F: CCCGTGGTCATCTTGTTCTGT
R: TTTCTTGCAGGCTTTGGTCTCC
Thrombospondin-2 NM_00
F: CTGGTCCTGCTGGCTCTG
R: TGGTCTTGCGGTTGATGTTG
Thrombospondin-3 NM_00
F: ATCAGGACACCAAGGACAAC
R: GGACCAGGAGGCACATAATC
Thrombospondin-4 NM_00
F: TGATGATGATGATGACAATGATGG
R: CCGTCGCTGTTGCTATCC
Human 18s M1009
F: CGGACAGGATTGACAGATTGATAGC
R: TGCCAGAGTCTCGTTCGTTATCG
All primers were used at a ﬁnal concentration of 0.2 lM. The primers were d
USA).2.4. Generation of short hairpin RNA (shRNA) constructs and
transfections
The Oligonucleotide Retriever program from Cold Spring Harbor
Laboratory http://www.cshl.org/public/SCIENCE/hannon.html/ was
used to generate sequences that code for shRNA against TSP-1 (Gen-
Bank Accession No. NM_003246) shown in Table 2. The oligonucleo-
tide ends were modiﬁed, synthesized (Integrated DNA Technologies,
USA), annealed, directionally ligated into the XbaI and XhoI sites of
the vector IMG-800 (Imgenex, USA) and used to transform DH5a
cells. Plasmid DNA was puriﬁed from positive E. coli colonies using
an endo-free puriﬁcation kit (Qiagen, USA). The sequences of the
cloned oligonucleotides were veriﬁed by automatic DNA sequencing
and used for transfection of HeLa cells. HeLa cells were used for stable
transfections because of the lack of RNAi vectors to eﬃciently trans-
fect primary cell lines. Cells were transfected with 5 lg plasmid in
OPTI-MEM (Invitrogen) using a lipid based transfection reagent
and selected with G418 (600 lg/ml) as described (Imgenex).
2.5. Immunoblotting
Cell monolayers were solubilized in 0.1% CHAPS containing prote-
ase inhibitors [13]. The same protein concentrations of all samples were
separated by SDS–PAGE, transferred onto nitrocellulose membranes,
probed with goat IgG to TSP-1, anti-ﬁbronectin, anti-laminin, or anti-
galectin-3 antibodies, developed using the Western Breeze chemilumi-
nescence kit (Invitrogen) as described [14]. Blots were stripped and re-
probed with a monoclonal IgG to b-actin. Immunoblots were also
performed using the same protein concentration of cell lysates of HeLa
or Vero cells starved in basal medium without fetal bovine serum for
24 h followed by incubation with or without TGF-b1 at the concentra-
tion of 5 ng/ml in basal medium as described in Section 2.2.5 0)
TTG AAGCTTGAGCAGGATGGTGGTTGGAGTATGGTTCCCGTTTTTTT
TCGAA CTCGTCCTACCACCAACCTCATACCAAGGGCAAAAAAAGATC
TCGAAGCTTGGAGTGACGGGGATGTACAGCATGGTTCCCGTTTTTTT
TCGAACCTCACTGCCCCTACATGTCGTACCAAGGGCAAAAAAAGATC
TCCG AAGCTTGGGAGGCAGGGGCTGCGTTGGTGGTGTAATAGTTTTTT
TCGAA CCCTCCGTCCCCGACGCAACCACCACATTATCAAAAAAGATC
GAGAAGCTT GTTACGAGGATTCGGCTCTGTAACTCTCCCAGTTTTTT
TCGAA CAATGCTCCTAAGCCGAGACATTGAGAGGGTCAAAAAAGATC
and cloned into the XbaI and SalI sites (underlined) of the IMG-800
eparate sense from antisense shRNAi in regular text. The scrambled T1
ank Accession Nos. Amplicon size (bp)
3246 133
3247 106
7112 133
3248 105
8 118
esigned using the Beacon Designer Software package (Premier Biosoft,
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The same concentration of transfected cells was added in triplicate
to 6-well tissue culture plates. Wild type HeLa cells were used as a con-
trol. After 4 h, the number of cells attached to wells was microscopi-
cally determined.
2.7. Presentation of results and statistical analysis
Results in this work were obtained from triplicate values and repre-
sent three independent experiments with identical protocols. Results
are expressed as the means ± 1 S.D. Diﬀerences were considered to
be statistically signiﬁcant if P < 0.05 as determined by Student’s t test.3. Results and discussion
Since intracellular parasites must cross the ECM and inter-
act with cellular matrix proteins in order to attach and invade
host cells, we explored the possibility that T. cruzi modulates
the ECM gene expression proﬁle in HCASM cells. We evalu-
ated the kinetics of change in gene transcript proﬁles of TSP-
1, TSP-2, TSP-3 and TSP-4 by real time PCR during the early
process of infection of HCASM cells by T. cruzi. Fig. 1 shows
that the TSP-1 transcript levels increased approximately 6-fold
at 60 min, followed by an increase of 2.7-fold at 120 min dur-
ing infection of HCASM cells by T. cruzi. The transcript levels
of TSP-2, TSP-3 and TSP-4 did not change signiﬁcantly during
the same period of time of T. cruzi infection of HCASM cells
(Fig. 1). These results indicate that early infection of HCASM
cells by T. cruzi upregulates the level of the TSP-1 transcript.
T. cruzi increased the level of TSP-1 transcript in HeLa cells
up to 2.1 ± 0.1-fold (P < 0.05) at 1 h when compared to mock
treated cells as evidenced by real-time PCR. Quantitative
immunoblot analysis indicates that the level of TSP-1 protein
in infected HeLa cells at 1 h also increased by 2 ± 0.08-fold1-PST
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Fig. 1. Kinetics of host TSP-1, TSP-2, TSP-3 and TSP-4 transcripts
during early infection of HCASM cells by T. cruzi. RNA from cells
exposed or not to T. cruzi was reversed transcribed to cDNA and the
levels of TSP-1 to -4 transcripts were evaluated by real-time PCR. Data
shown represent the means ± 1 S.D. of TSP-1 to -4 transcript levels
normalized against human 18s RNA in one representative experiment
of three independent experiments performed in triplicate with similar
results. Each point is the mean of results for triplicate samples in one
representative experiment (±1 S.D.). The P value was <0.05 for the
TSP-1 transcript at 60 and 120 min with respect to TSP-2 to -4
transcripts at the same times.(P < 0.05), indicating a direct relationship between TSP-1 tran-
script and protein levels. The levels of TSP-1 reached normal
levels at 2 h. No statistically signiﬁcant changes (P < 0.05) in
TSP-2, -3, and -4 transcripts were seen in HeLa cells at 1 or
2 h.
The fact that the T. cruzi infection upregulates the expres-
sion of TSP-1 prompted us to determine the function of the
TSP-1 gene in the process of T. cruzi infection of human cells
by stable RNAi. We investigated whether shRNA targeted to
TSP-1 could knock down its transcript. Three short nucleotide
sequences derived from the TSP-1 coding sequence were
cloned into IMG 800 vector (Imgenex). The sequences spanned
nucleotides 1477–1496 (T1), 1758–1786 (T2), and 1546–1574
(T3). The T1 sequence was scrambled and used as an addi-
tional control. The morphology and growth rate of human
cells stably transfected with the cloned constructs and selected
with neomycin remained unchanged following several pas-
sages. With the aid of quantitative real-time PCR we deter-
mined the level of the TSP-1 transcripts in the transfected
cells. We observed that one of the three constructs, named
T1, signiﬁcantly decreased the TSP-1 gene transcript by 70%
as compared to the cells transfected with vector alone and
scrambled T1 (Fig. 2), indicating that expression of this
shRNA was eﬀective in knocking-down the TSP-1 transcript.
T2 and T3 constructs were not as eﬀective as T1. Overexpres-
sion of TSP-1 in HeLa cells (Fig. 4C upper panel), induced by
TGFb-1, caused a signiﬁcant increase in both trypanosome
binding to cells at 2 h (Fig. 4C middle panel) and parasite load
at 72 h (Fig. 4C, lower panel). Overexpression of TSP-1 in-
duced by TGF-b1 was also seen in culture supernatants. These
results indicate that there is a direct correlation between over-
expression of TSP-1 in HeLa cells with an increase of infection
of these cells. Similar results were seen when Vero cells were
used instead of HeLa cells. The overexpression of TSP-1 in
human cells induced by TGF-b1 is consistent with previous
reports [15,16]. The enhancement of T. cruzi infection of
mammalian cells caused by pretreatment of cells with TGF-
b1 that we observed is also consistent with previous reports0
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Fig. 2. RNAi of the TSP-1 gene reduces the levels of the TSP-1
transcript in HeLa cells. RNA from HeLa cells stably transfected with
IMG-800 vector alone or vector containing construct T1, T2, T3 or
scrambled T1 was reversed transcribed to cDNA and the level of TSP-
1 transcripts evaluated by real-time PCR. The results were normalized
against human 18s RNA. Bars represent the means of results from
triplicate samples in one representative experiment (±1 S.D.) selected
from three independent experiments with similar results. *, signiﬁcant
diﬀerence compared to control value, cells transfected with vector
alone or scrambled T1 (P < 0.05).
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with construct T1 to exogenous recombinant TSP-1 at the con-
centration of 8 lg/ml for 30 min resulted in restoration of the
infection of these cells by 80.4% ± 6.1 (P < 0.05).
We further investigated whether the reduction of the TSP-1
gene transcript by RNAi was reﬂected at the protein level by
immunoblotting analysis. Our results indicate that the expres-
sion of TSP-1 in human cells stably transfected with the T1
construct was signiﬁcantly reduced as compared to wild type
cells, cells transfected with vector alone or scrambled T1
(Fig. 3A). Determination of the relative absorbance of TSP-1
and b-actin bands showed that RNAi of TSP-1 signiﬁcantly
decreased the protein level by 89% (Fig. 3B). The expression
of other ECM proteins (ﬁbronectin and laminin) and galec-
tin-3 in transfected HeLa cells remained unchanged as evi-
denced by immunoblots (Fig. 3C). We also observed that
transfected cells showed no diﬀerences in adhesion to substrate
compared to wild type HeLa cells (Fig. 3D). Furthermore,
immunoﬂuorescence studies of transfected and wild type cells
probed with anti-ﬁbronectin, anti-laminin and anti-galectin-3
antibodies showed no signiﬁcant diﬀerences in the expression
of these proteins with respect to wild type, cells transfected
with scrambled T1 or vector alone.
To determine the function of TSP-1 in the process of T. cruzi
infection, we exposed human cells presenting the new pheno-
type to invasive trypomastigotes. We observed that RNAi ofFig. 3. RNAi of TSP-1 knocks-down TSP-1 expression in HeLa cells withou
cell adhesion to substrate. (A) Immunoblot of HeLa cells transfected with v
cells stably transfected with either IMG-800 vector alone, construct T1, or s
antibodies in immunoblots. Wild type HeLa cells were used as an additional c
performed with similar results. (B) Densitometric scanning of immunoblots n
A. The mean ± 1 S.D. of three independent experiments is plotted. Bars repr
transfected with the vector alone or the chimeric vector-containing construct
control values, cells transfected with vector alone or scrambled T1 (P < 0.05)
cell lysates (5 lg) were separated on 8.5% polyacrylamide gel under reduci
ﬁbronectin, laminin, and galectin-3 and developed by ECL. This is a represen
of transfected HeLa cells to substrate. The same concentration of transfecte
HeLa cells were used as a control. After 4 h the number of attached cells we
experiment is plotted. This is a representative experiment of three performedTSP-1 dramatically reduced the number of trypomastigotes
that attached to human cells stably transfected with the T1
construct compared to cells transfected with vector alone
and scrambled T1. Human cells expressing the eﬀective
shRNA had less parasites bound per cell as compared to
mock-transfected cells at 2 h of T. cruzi infection (Fig. 4A).
We also observed that cells transfected with the T1 construct
presented a low parasite load at 72 h as compared to cells
transfected with vector alone or scrambled T1 (Fig. 4B). The
infection rate of HeLa cells transfected with construct T1 at
2 h was signiﬁcantly reduced up to 60% ± 5.2 (P < 0.05) with
respect to cells transfected with vector alone or scrambled
T1. Cells transfected with construct T1 presented a reduced
infection rate at 72 h up to 58% ± 7.5 (P < 0.05) with respect
to cells transfected with vector alone or scrambled T1.
The fact that less trypanosomes bind to cells stably transfec-
ted with the T1 construct (Fig. 4A) at 2 h consequently caused
less parasites to enter and multiply within these cells at 72 h
with respect to cells transfected with vector alone or vector con-
taining scrambled T1 (Fig. 4B). Analysis of parasite multiplica-
tion at 72 h indicated that cells transfected with vector alone
and vector containing scrambled T1 had a higher number of
parasites per cell, whereas cells transfected with the T1 con-
struct had signiﬁcantly lower number of parasites per cell.
These results indicate that RNAi of TSP-1 substantially re-
duced the transcript and its encoded protein, rendering the hu-t aﬀecting the expression of other ECM proteins, galectin-3, as well as
ector alone, construct T1, or scrambled T1. Five micrograms of HeLa
crambled T1 were probed with either TSP-1 antibodies or with b-actin
ontrol. The results shown are from a representative experiment of three
ormalized to their corresponding b-actin absorbance as shown in panel
esent normalized absorbance of TSP-1 bands from wild type cells, cells
T1 or scrambled T1, respectively. *, signiﬁcant diﬀerence compared to
. (C) Immunoblot analysis of ﬁbronectin, laminin and galectin-3. HeLa
ng conditions, blotted onto nitrocellulose, probed with antibodies to
tative experiment of three performed with similar results. (D) Adhesion
d cells was added in triplicate to 6 well tissue culture plates. Wild type
re microscopically determined. The mean ± 1 S.D. of a representative
with similar results.
Fig. 4. RNAi of TSP-1 signiﬁcantly reduces trypanosome infection. (A) RNAi of TSP-1 inhibits trypanosome adhesion to human cells. HeLa cells
stably transfected with IMG-800 vector alone or vector containing construct T1 or scrambled T1, were exposed to trypomastigotes at the ratio of
eight parasites per cells for 2 h and trypanosome binding was evaluated. (B) RNAi of TSP-1 reduces parasite load in human cells at 72 h. T. cruzi
multiplication in HeLa cells transfected with IMG-800, construct T1 or scrambled T1 was evaluated at 72 h. Bars represent the means ± 1 S.D. of
results from triplicate samples in one representative experiment (±1 S.D.) selected from three experiments with similar results. *, signiﬁcant diﬀerence
compared to control values, cells transfected with vector alone or scrambled T1 (P < 0.05). (C) Overexpression of TSP-1 in human cells increases T.
cruzi infection. (Upper panel C) Immunoblot analysis of TSP-1 expression in HeLa cells exposed to TGF-b1. HeLa cells were incubated in the
absence or presence of TGF-b1 (5 ng/ml) for 24 h. Eight micrograms of solubilized cells were separated by SDS–PAGE, blotted onto nitrocellulose
membranes and probed with anti-TSP-1 or anti-b-actin antibodies and developed by ECL. The results shown are from a representative experiment of
three performed with similar results. (Middle panel C) Overexpression of TSP-1 in HeLa cells causes increase of trypanosome binding. Binding of
trypomastigotes to untreated or TGF-b1 treated HeLa cells, under conditions indicated in upper panel C, was evaluated at 2 h using a parasite to cell
ratio of 5. (Lower panel C) Overexpression of TSP-1 in HeLa cells increases parasite load at 72 h. T. cruzi multiplication in HeLa cells was evaluated
at 72 h. Bars represent the means of ±1 S.D. of results from triplicate samples in one representative experiment (±1 S.D.) selected from three
experiments with similar results. *, signiﬁcant diﬀerences compared to control values, cells not treated with TGF-b1 expressing background levels of
TSP-1 (P < 0.05).
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tion. Our ﬁndings, showing that RNAi of TSP-1 causes a dra-
matic reduction of T. cruzi infection of human cells, indicates
that TSP-1 is required for the process of T. cruzi infection.
The residual T. cruzi infection seen indicates that the parasite
may use other TSP-1 independent mechanisms to infect cells.
T. cruzi infection causes extensive ﬁbrosis and severe cardio-
myopathology in the heart, which is in part vasculopathy,
leading to cardiac arrest that is frequently followed by death
[19]. T. cruzi must navigate through the basal lamina, which
contains TSP-1, and surrounds individual muscle cells such
as HCASM cells before infecting these cells. The fact that T.
cruzi trypomastigotes increased TSP-1 transcripts in HCASM
cells suggest that TSP-1 may contribute in part to the pathol-
ogy caused by T. cruzi.
Previous studies in our laboratory have shown that T. cruzi
trypomastigote gp83, a molecule that the parasite uses to at-
tach to host cells, upregulates laminin c-1 [20], whereas others
have shown that T. cruzi uncharacterized antigens upregulate
laminin, ﬁbronectin, and type I collagen [21].
Our observations that T. cruzi remodels the ECM by upregu-
lating the expression of TSP-1 indicate that the parasite exploitsTSP-1 to navigate through the ECM to facilitate infection. Here
we show that TSP-1 is required for the infection process of T.
cruzi as evidenced by RNAi of that speciﬁc isoform.
In summary, we report the novel ﬁndings that T. cruzi
upregulates the expression of host TSP-1 which facilitates the
infection of human cells. Thus, T. cruzi modiﬁes TSP-1 expres-
sion in the ECM to contribute to the pathogenesis of T. cruzi
infection.
Acknowledgements: This work was supported by NIH Grants GM
08037, AI 07281, AI 056667, HL 007737, MD 000551 and RR 003032.References
[1] Lawler, J. (2000) The functions of thrombospondin-1 and -2.
Curr. Opin. Cell Biol. 12, 634–640.
[2] Jurk, K., Clemetson, K.J., de Groot, P.G., Brodde, M.F., Steiner,
M., Savion, N., Varon, D., Sixma, J.J., Van Aken, H. and Kehrel,
B.E. (2003) Thrombospondin-1 mediates platelet adhesion at high
shear via glycoprotein Ib (GPIb): an alternative/backup mecha-
nism to von Willebrand factor. FASEB J. 17, 1490–1492.
[3] Chen, H., Herndon, M.E. and Lawler, J. (2000) The cell biology
of thrombospondin-1. Matrix Biol. 19, 597–614.
2370 K.J. Simmons et al. / FEBS Letters 580 (2006) 2365–2370[4] Hiscott, P., Paraoan, L., Choudhary, A, Ordonez, J.L., Al-
Khaier, A. and Armstrong, D.J. (2006) Thrombospondin 1,
thrombospondin 2 and the eye. Prog. Retin. Eye Res. 25, 1–8.
[5] Elzie, C.A. and Murphy-Ullrich, J.E. (2004) The N-terminus of
thrombospondin: the domain stands apart. Int. J. Biochem. Cell
Biol. 36, 1090–1101.
[6] Adams, J.C. and Lawler, J. (2004) The thombospondins. Int. J.
Biochem. Cell Biol. 36, 961–968.
[7] Bornstein, P. (2001) Thrombospondins as matricellular modula-
tors of cell function. J. Clin. Invest. 107, 929–934.
[8] Giordano, R., Fouts, D.L., Tewari, D., Colli, W., Manning, J.E.
and Alves, M.J.M. (1999) Cloning of a surface membrane
glycoprotein speciﬁc for the infective form of Trypanosoma cruzi
having adhesive properties to laminin. J. Biol. Chem. 274, 3461–
3468.
[9] Moody, T.N., Ochieng, J. and Villalta, F. (2000) Novel mecha-
nism that Trypanosoma cruzi uses to adhere to the extracellular
matrix mediated by human galectin-3. FEBS Lett. 470, 305–308.
[10] Ulrich, H., Magdesian, M.H., Alves, M.J.A. and Colli, W. (2002)
In vitro selection of RNA aptamers that bind to cell adhesion
receptors of Trypanosoma cruzi and inhibit cell invasion. J. Biol.
Chem. 277, 20756–20762.
[11] Lima, M.F. and Villalta, F. (1989) Trypanosoma cruzi trypomas-
tigote clones diﬀerentially express a parasite cell adhesion
molecule. Mol. Biochem. Parasitol. 33, 159–170.
[12] Kleshchenko, Y.Y., Moody, T.N., Furtak, V.A., Ochieng, J.,
Lima, M.F. and Villalta, F. (2004) Human galectin-3 promotes
Trypanosoma cruzi adhesion to human coronary artery smooth
muscle cells. Infect. Immun. 72, 6717–6721.
[13] Villalta, F., Smith, C., Ruiz-Ruano, A. and Lima, M.F. (2001) A
ligand that Trypanosoma cruzi uses to bind to mammalian cells to
initiate infection. FEBS Lett. 505, 383–388.[14] Alexander, D.A., Villalta, F. and Lima, M.F. (2003) Transform-
ing growth factor alpha binds to Trypanosoma cruzi amastigotes
to induce signaling and cellular proliferation. Infect. Immun. 71,
4201–4205.
[15] Mimura, Y., Ihn, H., Jinnin, M., Asano, Y., Yamane, K. and
Tamaki, K. (2005) Constitutive thrombospondin-1 overexpres-
sion contributes to autocrine transforming growth factor-b
signaling in cultured scleroderma ﬁbroblasts. Am. J. Pathol.
166, 1451–1463.
[16] Nakagawa, T., Li, J.H., Garcia, G., Mu, W., Piek, E., Bottinger,
E., Chen, Y., Zhu, H.J., Kang, D-H., Schreiner, G.F., Lan, H.Y.
and Johnson, R.J. (2004) TGF-b induces proangiogenic and
antiangiogenic factors via parallel but distinct Smad pathways.
Kidney. Int. 66, 605–613.
[17] Ming, M., Ewen, M.E. and Pereira, M.E.A. (1995) Trypanosome
invasion of mammalian cells requires activation of the TGF-b
signaling pathway. Cell 82, 287–296.
[18] Hall, B.S. and Pereira, M.A. (2000) Dual role for transforming
growth factor b-dependent signaling in Trypanosoma cruzi infec-
tion of mammalian cells. Infect. Immun. 68, 2077–2081.
[19] Tanowitz, H.B., Kirchhoﬀ, L.V., Simon, D., Morris, S.A., Weiss,
L.M. and Wittner, M. (1992) Chagas’ disease. Clin. Microbiol.
Rev. 5, 400–419.
[20] Nde, P.N., Simmons, K.J., Kleshchenko, Y.Y., Pratap, S., Lima,
M.F. and Villalta, F. (2006) Silencing of laminin c-1 gene blocks
Trypanosoma cruzi infection. Infect. Immun. 74, 1643–1648.
[21] Pinho, R.T., Vannier-Santos, M.A., Alves, C.R., Marino,
A.P.M.P., Castello Bronco, L.R.R. and Lannes-Vieira, J.
(2002) Eﬀect of Trypanosoma cruzi released antigens binding to
non-infected cells on anti-parasite antibody recognition and
expression of extracellular matrix components. Acta Trop. 83,
103–115.
